Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9
Abstract Congenital hyperinsulinism (CHI) is a rare genetic disorder characterized by excess insulin secretion, which results in hypoglycemia. Mutation of sulfonylurea receptor 1 (SUR1), encoded by the ABCC8 gene, is the main cause of CHI. Here, we captured the phenotype of excess insulin secretion...
Main Authors: | Dongsheng Guo, Haikun Liu, Aynisahan Ruzi, Ge Gao, Abbas Nasir, Yanli Liu, Fan Yang, Feima Wu, Guosheng Xu, Yin-xiong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-03349-w |
Similar Items
-
Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8
by: Julie Mouron-Hryciuk, et al.
Published: (2021-03-01) -
Genotyping of ABCC8, KCNJ11, and HADH in Iranian Infants with Congenital Hyperinsulinism
by: Somayyeh Hashemian, et al.
Published: (2021-01-01) -
Congenital hyperinsulinism in two siblings with ABCC8 mutation: same genotype, different phenotypes
by: Francisco Sousa-Santos, et al. -
Understanding the molecular basis of Congenital Hyperinsulinism due to autosomal dominant ABCC8 and KCNJ11 mutations
by: Nessa, A.
Published: (2014) -
Congenital hyperinsulinism
by: Indrė Petraitienė, et al.
Published: (2014-01-01)